文献速递妇产影像USMR

高危女性使用超声或磁共振成像诊断胎盘植入谱系疾病:系统综述与Meta分析

Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-03-10

该系统综述与Meta分析纳入17项观察性研究共1301名有胎盘植入谱系疾病(PAS)危险因素的女性,评估超声与MRI的诊断准确性。超声敏感度0.833、特异度0.834,MRI敏感度0.838、特异度0.831,两种方法间无统计学显著差异,但研究间异质性高。作者认为在高危人群中初始筛查选择何种影像方法应取决于设备可用性和检查者经验。

要点

  • 超声诊断PAS敏感度0.833(95%CI 0.776-0.878)、特异度0.834(95%CI 0.746-0.897)。
  • MRI诊断PAS敏感度0.838(95%CI 0.786-0.879)、特异度0.831(95%CI 0.770-0.878)。
  • 超声与MRI诊断准确性无统计学显著差异,初始筛查方法选择取决于设备与检查者经验。

核心结论

  • 超声与MRI诊断胎盘植入谱系疾病的准确性相似,在高危因素高流行环境中初始筛查影像方法的选择应取决于设备可用性和检查者专业经验。

研究设计与样本

  • 系统综述与Meta分析,遵循Cochrane诊断试验准确性综述指南,检索PubMed、EMBASE、PMC、Cochrane Library和BVS-Bireme五个数据库(2020年7月27日至8月4日,2021年8月18日更新),纳入2011至2021年发表的英文观察性研究;最终纳入17项研究共1301名同时具备MRI和超声数据的女性,其中457例经术中或组织病理学分析确诊PAS;采用QUADAS-2评估研究质量,总体质量令人满意。

诊断标准与关键数值

  • 超声诊断PAS的敏感度为0.833(95%CI 0.776-0.878),特异度为0.834(95%CI 0.746-0.897);MRI诊断PAS的敏感度为0.838(95%CI 0.786-0.879),特异度为0.831(95%CI 0.770-0.878);参考标准为术中或组织病理学分析;两种方法间无统计学显著差异;Cochran Q值提示超声和MRI的敏感度与特异度在研究间存在高水平异质性。

临床应用与阅片要点

  • 在高危因素高流行环境中,初始筛查PAS的影像方法选择应取决于设备可用性和检查者专业经验。

局限性

  • 超声和MRI的敏感度与特异度在研究间存在高水平异质性(Cochran Q值提示)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To perform a systematic review and meta-analysis of the diagnostic test accuracy of ultrasound and magnetic resonance imaging (MRI) and compare the performance of the two modalities in the diagnosis of placenta accreta spectrum (PAS).

METHODS: This was a systematic review conducted following the Cochrane Diagnostic Test Accuracy Reviews guideline. A literature search was performed in five databases: PubMed, EMBASE, PMC, The Cochrane Library and BVS-Bireme between 27 July and 4 August 2020. The search was updated on 18 August 2021. We included observational studies evaluating diagnostic accuracy in women with risk factors for PAS who had undergone both ultrasound and MRI examinations, published in English between 2011 and 2021. Quality Assessment of Diagnostic Accuracy Studies-2 was used to evaluate the quality of the studies. Forest plots for sensitivity and specificity with 95% CIs and receiver-operating-characteristics curves for ultrasound and MRI were constructed.

RESULTS: The literature search identified 266 studies. After reviewing the titles and abstracts of the articles, 51 were selected for full-text review and 17 studies including 1301 women with MRI and ultrasound data available were selected for the meta-analysis. The study population included 457 cases with PAS diagnosed using the gold standard method (intraoperative or histopathological analysis). The overall quality of the evaluated studies was considered satisfactory according to QUADAS-2. The meta-analysis revealed a sensitivity of 0.833 (95% CI, 0.776-0.878) and specificity of 0.834 (95% CI, 0.746-0.897) for ultrasound. For MRI, sensitivity was 0.838 (95% CI, 0.786-0.879) and specificity was 0.831 (95% CI, 0.770-0.878). There was no statistically significant difference between the two modalities. The Cochran's Q values indicated a high level of heterogeneity of sensitivity and specificity of ultrasound and MRI across studies.

CONCLUSIONS: Ultrasound and MRI have similar accuracy in the diagnosis of PAS. These results suggest that, in a setting with a high prevalence of risk factors, the choice of imaging modality for initial screening for PAS should depend on the availability of equipment and the examiner's expertise. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, et al. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 35041250. doi:10.1002/uog.24861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。